全文获取类型
收费全文 | 67篇 |
免费 | 10篇 |
专业分类
妇产科学 | 1篇 |
基础医学 | 3篇 |
临床医学 | 18篇 |
内科学 | 38篇 |
皮肤病学 | 1篇 |
外科学 | 9篇 |
综合类 | 1篇 |
预防医学 | 2篇 |
药学 | 2篇 |
肿瘤学 | 2篇 |
出版年
2018年 | 1篇 |
2017年 | 3篇 |
2015年 | 6篇 |
2014年 | 3篇 |
2013年 | 2篇 |
2012年 | 3篇 |
2010年 | 1篇 |
2009年 | 5篇 |
2008年 | 1篇 |
2006年 | 2篇 |
2005年 | 1篇 |
2003年 | 1篇 |
2000年 | 1篇 |
1999年 | 3篇 |
1998年 | 5篇 |
1997年 | 8篇 |
1996年 | 1篇 |
1995年 | 7篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1983年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1966年 | 1篇 |
1957年 | 2篇 |
排序方式: 共有77条查询结果,搜索用时 31 毫秒
71.
Electroanatomic Mapping to Identify Breakthrough Sites in Recurrent Typical Human Flutter 总被引:4,自引:0,他引:4
JASBIR SRA ATUL BHATIA ANWER DHALA ZALMEN BLANCK SHARAD RATHOD BIRENDER BOVEJA SANJAY DESHPANDE RYAN COOLEY MASOOD AKHTAR 《Pacing and clinical electrophysiology : PACE》2000,23(10):1479-1492
SRA, J., et al. : Electroanatomic Mapping to Identify Breakthrough Sites in Recurrent Typical Human Flutter. The accuracy of conventional techniques in localizing previous radiofrequency (RF) ablation sites and thus breakthrough sites of recurrent atrial flutter is somewhat limited. We investigated the role of electroanatomic mapping for identifying breakthrough sites or "gaps" at the tricuspid annulus and inferior vena cava (IVC)/eustachian ridge isthmus to help RF ablation in patients with recurrent typical flutter. Twelve patients ( 8 men, 4 women, age 63 ± 10 years ) with recurrent typical atrial flutter were included in the study. An electroanatomic mapping system (CARTO) was used to create a voltage map and activation and propagation patterns in the right atrium. Detailed voltage, activation, and propagation mapping of the tricuspid annulus and IVC/eustachian ridge isthmus allowed precise identification of gaps in all 12 patients at the tricuspid annulus (eight sites), IVC ridges (two sites), mid-isthmus region (one site), and tricuspid annulus and IVC ridges (one site). Radiofrequency energy directed at these sites eliminated atrial flutter in all 12 patients, confirmed by noninducibility of atrial flutter and demonstration of conduction block during atrial pacing on either side of the lesion lines. During a mean follow-up of 14.8 ± 3.5 months ( range 8–19 months ), paroxysmal atrial flutter recurred in only one patient and was subsequently treated with amiodarone, although this had been ineffective prior to ablation. Electroanatomic mapping can precisely identify gaps in the lesion line responsible for breakthrough of recurrent typical atrial flutter at the tricuspid annulus and at the IVC/eustachian ridge isthmus. These sites can be targeted with RF ablation with a high degree of success. 相似文献
72.
73.
MOHAMMAD R. JAZAYERI M.D. SANJAY S. DESHPANDE M.D. JASBIR S. SRA M.D. MASOOD AKHTAR M.D. 《Journal of cardiovascular electrophysiology》1993,4(3):280-287
Retrograde Right Bundle Branch Activation. A 40-year-old man undergoing electro-physiologic study for recurrent palpitations was found to have a right bundle branch block during sinus rhythm and right bundle potentials occurring after ventricular activation. The sequence of activation of the proximal and distal right bundle potentials was suggestive of a retrograde invasion of the right bundle during sinus rhythm. This transseptal activation of the right bundle via the left bundle exhibited decremental conduction characteristics during atrial as well as ventricular stimulation. Observations made in this case may provide some important information concerning the electrophysiologic behavior of transseptal impulses. 相似文献
74.
ANDREA NATALE JASBIR SRA ANWER DHALA ABDUL WASE MOHAMMAD JAZAYERI SANJAY DESHPANDE ZALMEN BLANCK MASOOD AKHTAR 《Pacing and clinical electrophysiology : PACE》1995,18(4):655-662
Objectives: The purpose of this study was to evaluate the efficacy of different therapeutic approaches for patients with a history of syncope and positive head-up tilt testing. Background: Head-up tilt testing has gained broad acceptance as a reliable diagnostic method for the assessment of patients with recurrent unexplained syncope. However, once the diagnosis is established, there is no consensus on the most appropriate treatment. In this respect, efficacy of drug therapy in preventing recurrence of symptoms in such patients is not entirely clear, and controversies exist regarding the need to confirm the effects of pharmacological interventions. Methods: Clinical follow-up was obtained in 303 patients with a history of syncope and positive head-up tilt testing. After the diagnostic head-up tilt, patients were assigned to different therapeutic approaches according to their preference or logistic impediments. Of 303 patients, 44 received empiric therapy, 210 were treated with medications proven effective during repeated head-up tilt testing, and 49 refused or discontinued medical therapy. The three groups were similar with regard to age, sex, and clinical presentation. The mean follow-up was 2.8 ±1.8 years. Among the patients treated according to head-up tilt guided therapy, 130 were on beta blockers, 35 on theophylline, 10 on ephedrine, 31 on disopyramide, and 4 on miscellaneous regimens. Empiric treatment consisted of beta blockers in 37 of 44 patients and other drugs in the remaining patients. Results: During the follow-up, recurrence of symptoms was experienced in 12 (6%) of the 210 patients receiving the head-up tilt guided therapy, 16 (36%) of 44 in the empiric therapy group, and 33 (67%) of 49 in the no therapy group. Recurrence of symptoms in patients on empiric or no therapy was significantly more frequent as compared to the head-up tilt guided therapy group (P<0.01). Conclusions: In patients with unexplained syncope and positive upright tilt testing, therapeutic strategies identified on the basis of response during head-up tilt have a more positive impact on the recurrence of symptoms during follow-up. 相似文献
75.
R. DENT UNDERWOOD M.D. SANJAY S. DESHPANDE M.D. MICHAEL BIEHL M.D. MARK COWAN M.D. MASOOD AKHTAR M.D. MOHAMMAD R. JAZAYERI M.D. 《Journal of cardiovascular electrophysiology》1995,6(11):1015-1022
Radiofrequency Ablation of Multiple VTs. Introduction : As treatment options for ventricular tachycardia (VT) continue to evolve, the use of radiofrequency catheter ablation is rapidly expanding. However, in the presence of multiple morphologies of VT, achieving successful results may seem less likely. We report two patients with multiple morphologies of VT who underwent successful radiofrequency ablation by application of adiofrequency energy to a single region in the left ventricle.
Methods and Results : Two patients, each without any apparent cardiac dysfunction and a history of documented VT, were referred to our institution for further management. They underwent an electrophysiologic study and were found to have easily inducible VT, of three morphologies in one patient and two in the other. Using a transaortic approach, left ventricular mapping was performed for detecting a site with presystolic potentials, earliest ventricular activation, or both. Application of radiofrequency energy to a single area in the left ventricle resulted in the elimination of all previously inducible VT in each patient.
Conclusion : VTs with distinctly different morphologies can occur in patients with no detectable structural heart disease. These VT circuits may share a common pathway and, therefore, may readily be amenable to therapy with radiofrequency catheter ablation. 相似文献
Methods and Results : Two patients, each without any apparent cardiac dysfunction and a history of documented VT, were referred to our institution for further management. They underwent an electrophysiologic study and were found to have easily inducible VT, of three morphologies in one patient and two in the other. Using a transaortic approach, left ventricular mapping was performed for detecting a site with presystolic potentials, earliest ventricular activation, or both. Application of radiofrequency energy to a single area in the left ventricle resulted in the elimination of all previously inducible VT in each patient.
Conclusion : VTs with distinctly different morphologies can occur in patients with no detectable structural heart disease. These VT circuits may share a common pathway and, therefore, may readily be amenable to therapy with radiofrequency catheter ablation. 相似文献
76.
Efficacy of Midodrine Hydrochloride in Neurocardiogenic Syncope Refractory to Standard Therapy 总被引:3,自引:0,他引:3
JASBIR SRA M.D. CHERYL MAGLIO R.N. MICHAEL BIEHL M.D. ANWER DHALA M.D. ZALMEN BLANCK M.D. SANJAY DESHPANDE M.D. MOHAMMAD R. JAZAYERI M.D. MASOOD AKHTAR M.D. 《Journal of cardiovascular electrophysiology》1997,8(1):42-46
Midodrine for Refractory Neurocardiogenic Syncope. introduction : Some patients with neurocardiogenic syncope continue to have recurrent syncope or presyncope despite the use of currently available drug therapy. The purpose of this study was to determine whether midodrine hydrochloride, a selective adrenergic agonist, could he effective in patients resistant to, or intolerant of, currently used medications in the treatment of neurocardiogenic syncope.
Methods and Results : Eleven patients with a history of recurrent syncope or presyncope in whom hypotension with syncope or presyncope could be provoked during head-up tilt testing were included. There were 4 men and 7 women with a mean age (± SD) age of 34 ± 13 years. In all patients, standard therapy with beta-adrenergic receptor blocking agents, ephedrine, theophylline, disopyramide, fludrocortisone, and sertraline hydrochloride, was either ineffective, poorly tolerated, or contraindicated. Midodrine was initially administered orally at a dose of 2.5 mg three times daily. After adjustment of dosage over 2 to 4 weeks, patients were followed-up clinically. Midodrine was discontinued in one patient because of side effects. Frequency of syncope or presyncope during the 3 months prior to starting treatment was compared during a mean follow-up of 17 ± 4 weeks after starting treatment with midodrine. There was significant (P < 0.01) reduction in syncopal and presyncopal episodes on midodrine. Five patients had complete resolution of symptoms, while four patients had significant improvement. Symptoms did not improve in one patient.
Conclusions : Midodrine hydrochloride can he effective in preventing recurrent symptoms in selected patients with neurocardiogenic syncope unresponsive to, or intolerant of, standard drug therapy. 相似文献
Methods and Results : Eleven patients with a history of recurrent syncope or presyncope in whom hypotension with syncope or presyncope could be provoked during head-up tilt testing were included. There were 4 men and 7 women with a mean age (± SD) age of 34 ± 13 years. In all patients, standard therapy with beta-adrenergic receptor blocking agents, ephedrine, theophylline, disopyramide, fludrocortisone, and sertraline hydrochloride, was either ineffective, poorly tolerated, or contraindicated. Midodrine was initially administered orally at a dose of 2.5 mg three times daily. After adjustment of dosage over 2 to 4 weeks, patients were followed-up clinically. Midodrine was discontinued in one patient because of side effects. Frequency of syncope or presyncope during the 3 months prior to starting treatment was compared during a mean follow-up of 17 ± 4 weeks after starting treatment with midodrine. There was significant (P < 0.01) reduction in syncopal and presyncopal episodes on midodrine. Five patients had complete resolution of symptoms, while four patients had significant improvement. Symptoms did not improve in one patient.
Conclusions : Midodrine hydrochloride can he effective in preventing recurrent symptoms in selected patients with neurocardiogenic syncope unresponsive to, or intolerant of, standard drug therapy. 相似文献
77.
Spontaneous Reinitiation of Atrial Fibrillation Following Transvenous Atrial Defibrillation 总被引:5,自引:0,他引:5
JASBIR SRA MICHAEL BIEHL ZALMEN BLANCK ANWER DHALA MOHAMMAD R. JAZAYERI SANJAY DESHPANDE MASOOD AKHTAR 《Pacing and clinical electrophysiology : PACE》1998,21(5):1105-1110
Spontaneous reinitiation of atrial fibrillation (AF) has not been systematically looked at in patients undergoing transvenous AF. This study involved 11 patients, the mean age 60 ± 8 years. 3 male and 8 female, in whom transvenous atrial defibrillation successfully converted AF to sinus rhythm. Eight patients had paroxysmal AF and three patients had chronic persistent AF for 4 weeks or more. Four patients were taking antiarrhythmic medications at the time of testing. Multipolar transvenous catheters were positioned inside the coronary sinus, right atrium, and the right ventricle. Atrial defibrillation testing was performed using the METRIX atrial defibrillation system in nine patients and the Ventritex HVSO2 in the remaining two patients. A total of 64 therapeutic shocks (range 3–11) were delivered in the 11 patients, and 31 of these successfully converted AF to sinus rhythm. In four patients spontaneous AF was reinitiated following 12 successful transvenous atrial defibrillation episodes. The mean time to reinitiation of AF following shock delivery and restoration of sinus rhythm was 8.26 ± 5.25 seconds, range 1.8–19.9 seconds. All 12 episodes of spontaneous AF were preceded by a spontaneous premature atrial complex. The coupling interval of the premature atrial complexes was 443 ± 43 ms, range 390–510 ms. None of the patients taking antiarrhythmic medications or those demonstrating no premature atrial complexes had spontaneous reinitiation of AF. In conclusion, spontaneous reinitiation of AF can occur in a significant proportion of patients with AE undergoing transvenous atrial defibrillation. This phenomenon is preceded by the occurrence of atrial premature complex. Findings of this study may have significant clinical implications.(PACE 1998; 21:1105–1110) 相似文献